Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…
Press release – No. 10 / 2026 Zealand Pharma to Present Data atthe American Diabetes Association's 2026 Scientific Sessions Late-breaking…
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may…
May 22, 2026 18:00 ET | Source: Calidi Biotherapeutics, Inc SAN DIEGO, May 22, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics,…
Recognized for its innovation and customer-oriented approach in delivering reliable, scalable POTS-replacement solutions that enhance operational visibility and control.SAN ANTONIO,…
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s…
April 27, 2026 17:00 ET | Source: Arbor Biotechnologies Inc - Oral presentation highlights novel compact RT editor demonstrating first…
Recognized for delivering purpose-built broadcast services that enhance operational efficiency, reliability, and seamless end-to-end workflow integration.SAN ANTONIO, April 20, 2026…
ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a…
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical…